CLINICAL_TRIALS
trial_result
· 2021-11-09
Clinical Trial Update: A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 trial evaluating niraparib as a single agent in participants with advanced solid tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-11-09